收藏切换
Rethinking clinical status of migraine
收藏切换
Xiaoyan SONG1, Xiaoping WANG2, *
World Clinical Drug | 2023, 44(6) : 527 - 530
Less
收藏切换
World Clinical Drug | 2023, 44(6): 527-530
• Topic •
Rethinking clinical status of migraine
Full
Xiaoyan SONG1, Xiaoping WANG2, *
Affiliations
  • 1.Department of Neurology, Shanghai General Hospital, Shanghai 200080, China
  • 2.Neurological Disease Diagnosis and Treatment Center, Shanghai General Hospital Jiading Branch, Shanghai 201804, China
Published: 2023-06-10 doi: 10.13683/j.wph.2023.06.002
Outline
收藏切换

Migraine is a common and chronic disease that is characterized by episodic headache that can cause disability, accompanied by aura and other symptoms. The etiology is relatively unknown, and four rare related genes have been identified. The pathogenesis of migraine may be related to spreading depolarization, which probably causes aura and initiates activation of trigeminal pain pathway, ultimately triggering headache. Vasodilation is possibly a secondary phenomenon. The treatment of migraine varies according to the severity of the attack. Calcitonin gene related peptide (CGRP) receptor antagonists and selective 5-hydroxytryptamine 1F receptor agonist are expected to be effective in acute phase. Monoclonal antibodies targeting CGRP pathways and receptor antagonists are expected to prevent migraine because of their good efficacy and tolerance. Intramuscular injection of botulinum toxin A can be a treatment option for chronic migraine. The emergence of new medications indicates the bright future for migraine management.

migraine  /  diagnosis  /  treatment  /  prevention
宋小燕, 王晓平. 偏头痛临床现状再思考. 世界临床药物, 2023 , 44 (6) : 527 -530 . DOI: 10.13683/j.wph.2023.06.002
Xiaoyan SONG, Xiaoping WANG. Rethinking clinical status of migraine[J]. World Clinical Drug, 2023 , 44 (6) : 527 -530 . DOI: 10.13683/j.wph.2023.06.002
Year 2023 volume 44 Issue 6
16
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.06.002
  • Receive Date:2023-01-16
  • Online Date:2026-11-18
  • Published:2023-06-10
Article Data
Affiliations
History
  • Received:2023-01-16
Affiliations
    1.Department of Neurology, Shanghai General Hospital, Shanghai 200080, China
    2.Neurological Disease Diagnosis and Treatment Center, Shanghai General Hospital Jiading Branch, Shanghai 201804, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.06.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT